JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY HYDERABAD B. Pharmacy IV Year INDUSTRIAL PHARMACY - II Previous Question Paper (February-2022 - R17)

Pilot plant scale-up for solid dosage forms is the process of transitioning a laboratory-scale formulation into a viable commercial-scale production process. The primary objective is to ensure that the product quality, safety, and efficacy remain consistent while scaling up equipment size and batch volume.

Key considerations and techniques include:

• Equipment Selection: Equipment used in the pilot plant must be geometrically similar to the production-scale equipment. This ensures that the physical forces (e.g., shear, compression, mixing intensity) applied to the product are proportional across scales.
• Process Parameters: Critical Process Parameters (CPPs) such as impeller speed, granulation time, drying temperature, and compression force must be identified and optimized. Scale-up often involves maintaining constant parameters like tip speed or power-per-unit volume rather than just matching RPM.
• Granulation Techniques: During wet granulation, the liquid-to-solid ratio and the method of liquid addition are critical. The pilot plant must evaluate the impact of increased batch size on granule size distribution and moisture content to ensure consistent flow and compressibility.
• Drying: Scaling up drying processes (e.g., fluid bed drying) requires monitoring airflow, inlet temperature, and bed depth. The drying rate is often limited by mass transfer, which changes with the volume of the material in the dryer.
• Tableting: Compression scale-up focuses on dwell time and feeder speed. The pilot plant must assess the tablet's physical properties, such as hardness, friability, and disintegration time, at higher production speeds to ensure that the formulation can withstand the mechanical stress of high-speed rotary presses.
• Scale-up Reporting: A comprehensive scale-up report must document all deviations, adjustments to processing parameters, and analytical testing results (dissolution profiles, content uniformity) to provide a regulatory basis for commercial manufacturing.

The success of the scale-up is validated through Process Validation, where at least three consecutive batches are produced at commercial scale to demonstrate that the process consistently yields a product meeting all predetermined specifications.